Loading…

Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression

Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neithe...

Full description

Saved in:
Bibliographic Details
Published in:Developmental cell 2016-12, Vol.39 (6), p.638-652
Main Authors: Funk, Laura C., Zasadil, Lauren M., Weaver, Beth A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3
cites cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3
container_end_page 652
container_issue 6
container_start_page 638
container_title Developmental cell
container_volume 39
creator Funk, Laura C.
Zasadil, Lauren M.
Weaver, Beth A.
description Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy. Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.
doi_str_mv 10.1016/j.devcel.2016.10.023
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5204306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1534580716307614</els_id><sourcerecordid>27997823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EolB4A4T8AimOE8cJByRUsVQqiwRcuFjpeAKuWrvYSaW-PS5lvXCxPcv_j-cj5Chlg5Slxcl0oHEJOBvwGMXUgPFsi-ylpSyTVIh0O75FlieiZLJH9kOYstiYlmyX9LisKlnybI88j83S2BdqLB2Obk_pjWlda4CObGM0zky7orXVdNQGOnQ24FuHFjDQxnn62M3jee_dPEqc_Wh86BYLjyHE-IDsNPUs4OHn3SdPlxePw-tkfHc1Gp6PExC8ahPZ4ARYBkLIqpQTyaHRUBQCeaOlLEAjVBnjsqgLBpMyrxvgORes4MiZgDrrk7ON76KbzFED2tbXM7XwZl77lXK1UX8r1ryqF7dUgrM8Y0U0yDcG4F0IHptvbcrUmrWaqg1rtWa9zkbWUXb8e-636Avuz8cwbr806FUAs8anjUdolXbm_wnv78CULg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</creator><creatorcontrib>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</creatorcontrib><description>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy. Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</description><identifier>ISSN: 1534-5807</identifier><identifier>EISSN: 1878-1551</identifier><identifier>DOI: 10.1016/j.devcel.2016.10.023</identifier><identifier>PMID: 27997823</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aneuploidy ; Animals ; Carcinogenesis - pathology ; Chromosomal Instability ; CIN ; Humans ; Mitosis ; mitotic checkpoint ; Models, Biological ; Neoplasms - drug therapy ; Neoplasms - genetics ; Neoplasms - pathology ; spindle assembly checkpoint ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>Developmental cell, 2016-12, Vol.39 (6), p.638-652</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</citedby><cites>FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27997823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Funk, Laura C.</creatorcontrib><creatorcontrib>Zasadil, Lauren M.</creatorcontrib><creatorcontrib>Weaver, Beth A.</creatorcontrib><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><title>Developmental cell</title><addtitle>Dev Cell</addtitle><description>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy. Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</description><subject>Aneuploidy</subject><subject>Animals</subject><subject>Carcinogenesis - pathology</subject><subject>Chromosomal Instability</subject><subject>CIN</subject><subject>Humans</subject><subject>Mitosis</subject><subject>mitotic checkpoint</subject><subject>Models, Biological</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>spindle assembly checkpoint</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1534-5807</issn><issn>1878-1551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAQhi0EolB4A4T8AimOE8cJByRUsVQqiwRcuFjpeAKuWrvYSaW-PS5lvXCxPcv_j-cj5Chlg5Slxcl0oHEJOBvwGMXUgPFsi-ylpSyTVIh0O75FlieiZLJH9kOYstiYlmyX9LisKlnybI88j83S2BdqLB2Obk_pjWlda4CObGM0zky7orXVdNQGOnQ24FuHFjDQxnn62M3jee_dPEqc_Wh86BYLjyHE-IDsNPUs4OHn3SdPlxePw-tkfHc1Gp6PExC8ahPZ4ARYBkLIqpQTyaHRUBQCeaOlLEAjVBnjsqgLBpMyrxvgORes4MiZgDrrk7ON76KbzFED2tbXM7XwZl77lXK1UX8r1ryqF7dUgrM8Y0U0yDcG4F0IHptvbcrUmrWaqg1rtWa9zkbWUXb8e-636Avuz8cwbr806FUAs8anjUdolXbm_wnv78CULg</recordid><startdate>20161219</startdate><enddate>20161219</enddate><creator>Funk, Laura C.</creator><creator>Zasadil, Lauren M.</creator><creator>Weaver, Beth A.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20161219</creationdate><title>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</title><author>Funk, Laura C. ; Zasadil, Lauren M. ; Weaver, Beth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aneuploidy</topic><topic>Animals</topic><topic>Carcinogenesis - pathology</topic><topic>Chromosomal Instability</topic><topic>CIN</topic><topic>Humans</topic><topic>Mitosis</topic><topic>mitotic checkpoint</topic><topic>Models, Biological</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>spindle assembly checkpoint</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Funk, Laura C.</creatorcontrib><creatorcontrib>Zasadil, Lauren M.</creatorcontrib><creatorcontrib>Weaver, Beth A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Developmental cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Funk, Laura C.</au><au>Zasadil, Lauren M.</au><au>Weaver, Beth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression</atitle><jtitle>Developmental cell</jtitle><addtitle>Dev Cell</addtitle><date>2016-12-19</date><risdate>2016</risdate><volume>39</volume><issue>6</issue><spage>638</spage><epage>652</epage><pages>638-652</pages><issn>1534-5807</issn><eissn>1878-1551</eissn><abstract>Errors in chromosome segregation during mitosis have been recognized as a hallmark of tumor cells since the late 1800s, resulting in the long-standing hypothesis that mitotic abnormalities drive tumorigenesis. Recent work has shown that mitotic defects can promote tumors, suppress them, or do neither, depending on the rate of chromosome missegregation. Here we discuss the causes of chromosome missegregation, their effects on tumor initiation and progression, and the evidence that increasing the rate of chromosome missegregation may be an effective chemotherapeutic strategy. Errors in chromosome segregation are a hallmark of tumor cells. Furthermore, how mitotic defects affect tumors depends on the rate of chromosome missegregation. Funk et al. discuss causes of chromosome missegregation, their effects on tumor initiation and progression, and whether increasing chromosome missegregation rates may be an effective chemotherapeutic strategy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27997823</pmid><doi>10.1016/j.devcel.2016.10.023</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1534-5807
ispartof Developmental cell, 2016-12, Vol.39 (6), p.638-652
issn 1534-5807
1878-1551
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5204306
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Aneuploidy
Animals
Carcinogenesis - pathology
Chromosomal Instability
CIN
Humans
Mitosis
mitotic checkpoint
Models, Biological
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - pathology
spindle assembly checkpoint
Tumor Suppressor Protein p53 - metabolism
title Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A48%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Living%20in%20CIN:%20Mitotic%20Infidelity%20and%20Its%20Consequences%20for%20Tumor%20Promotion%20and%20Suppression&rft.jtitle=Developmental%20cell&rft.au=Funk,%20Laura%20C.&rft.date=2016-12-19&rft.volume=39&rft.issue=6&rft.spage=638&rft.epage=652&rft.pages=638-652&rft.issn=1534-5807&rft.eissn=1878-1551&rft_id=info:doi/10.1016/j.devcel.2016.10.023&rft_dat=%3Cpubmed_cross%3E27997823%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-7febc03c557987b72cfdc665e2fd776cdec930276a60cb84afc2425062e205ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27997823&rfr_iscdi=true